Therapy in diabetes type 2 comes down to medication, a strict diet, and the use of natural products like CBD oil or any of CBD-based products. A sugar disease is everything but sweet. Diabetes is one
Continue reading“These complications have a direct impact on the morbidity and mortality experienced by H SCT survivors. Two-thirds of HSCT survivors develop at least one chronic health condition; while a fifth
Continue readingIf you are not young, early stage (MM) and low-risk then, according to the research below, your average first remission will be about 2-3 years and your OS will be about the average 5-7 years. Hi David-
Continue reading“…based on 29 cases that progressed to MM or other LP diseases later in life, our study found midlife obesity to be a risk factor for progression among individuals diagnosed with MGUS.” Hi
Continue reading“The bone marrow microenvironment in multiple myeloma is characterized by an increased microvessel density. The production of pro-angiogenic molecules is increased and the production of angiogenic inhibitors
Continue reading“However, most patients eventually relapse and often demonstrate multiple drug resistance. Therefore there is still an urgent and unmet need to define the molecular mechanisms of resistance for available
Continue reading“hematopoietic stem cell transplant (HSCT) survivors are at risk of developing long-term complications, such as endocrinopathies, musculoskeletal disorders, cardiopulmonary compromise and subsequent
Continue readingtreatment of MGUS/SMM patients with curcumin resulted in an improvement in markers of disease progression (i.e., free light-chain ratio (rFLC), paraprotein levels, percentage plasma cells) in some patients
Continue readingA recent update confirmed an overall survival advantage after a median follow-up of more than six years,”How can overall survival be measured in pre-Multiple Myeloma (MGUS, SMM)? The oncologist in
Continue readingSmoldering multiple myeloma is a plasma cell disorder defined by the presence of a serum monoclonal component of at least 30 g/L and/or between 10% and 60% plasma cells in the bone marrow. Dear David-
Continue reading“Several lines of evidence point to a genetic predisposition to Multiple Myeloma and other plasma cell dyscrasias.” Hi David- Thanks for this information as it seems to be the only one of
Continue reading“…other therapeutic elements (e. g., other maintenance strategies, consolidation, tandem transplantation,..) have to be decided on an individualized appraisal of risk and toxicities…” My
Continue reading